Vertex Pharmaceuticals (VRTX)

EBITDA Margin

43.60%

TTM · Period ending:

VRTX logo

VRTX EBITDA Margin

Latest reported43.60%
VRTX TTM EBITDA Margin (-178.26% → 43.60%)
High-resolution chart · PNG

VRTX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Vertex Pharmaceuticals EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-69.9662%
-28.8565%
-37.0512%
-14.9302%
-17.7705%
-61.5078%
-70.7744%
-138.9236%
-86.6457%
-95.8838%
-78.5185%
-66%
-85.755%
-54.8628%
-35.1598%
-39.3048%
-61.9403%
-133.3333%
-200%
-138.3234%
-145.9627%
-131.7949%
-103.1674%
-174.0964%
-119.7115%
-103.6649%
-87.7551%
-0.2865%
2.7439%
16.8712%
18.2796%
-62.3853%
-89.3333%
-212.8205%
-182.0513%
-164.8649%
-148.5714%
-136.3636%
-68.75%
-226.6667%
-185.7143%
-146.1538%
-178.2609%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.